0000000001115229

AUTHOR

Maria Teresa Kong-sanchez

showing 1 related works from this author

A randomized, open-label, two-arm phase II trial comparing the efficacy of sequential ipilimumab (ipi) versus best supportive care (BSC) following fi…

2016

4011Background: Pts with advanced gastric cancer have a poor prognosis with median overall survival (OS) of ~1 yr. Ipi is a monoclonal antibody that enhances T-cell activation and T-effector cell t...

0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyFirst linemedicine.medical_treatmentGastro esophageal junctionLocally advancedIpilimumab03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesInternal medicinemedicineIn patientChemotherapybusiness.industryCancermedicine.diseaseSurgery030104 developmental biologyOncology030220 oncology & carcinogenesisOpen labelbusinessmedicine.drugJournal of Clinical Oncology
researchProduct